Deutsche Bank Ag\ Nurix Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 854,682 shares of NRIX stock, worth $16.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

854,682

Previous 1,048,394 18.48%

Holding current value

$16.9 Million

Previous $21.9 Million 12.3%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$18.93 - $25.69 $3.67 Million - $4.98 Million	-193,712 Reduced 18.48%	854,682 $19.2 Million
Q2 2024 Aug 14, 2024	SELL	$12.02 - $21.3 $5.42 Million - $9.61 Million	-450,974 Reduced 30.08%	1,048,394 $21.9 Million
Q1 2024 May 15, 2024	BUY	$7.77 - $15.66 $7.73 Million - $15.6 Million	995,163 Added 197.37%	1,499,368 $22 Million
Q4 2023 Feb 14, 2024	BUY	$4.25 - $10.71 $2.06 Million - $5.19 Million	484,610 Added 2473.13%	504,205 $5.2 Million
Q3 2023 Nov 09, 2023	BUY	$7.86 - $10.08 $30,190 - $38,717	3,841 Added 24.38%	19,595 $154,000
Q2 2023 Aug 14, 2023	SELL	$8.7 - $13.28 $110,133 - $168,111	-12,659 Reduced 44.55%	15,754 $157,000
Q1 2023 May 15, 2023	BUY	$8.56 - $13.26 $74,189 - $114,924	8,667 Added 43.89%	28,413 $252,000
Q4 2022 Feb 13, 2023	BUY	$9.86 - $14.59 $3,056 - $4,522	310 Added 1.59%	19,746 $216,000
Q3 2022 Nov 14, 2022	SELL	$12.33 - $19.81 $18,827 - $30,249	-1,527 Reduced 7.28%	19,436 $253,000
Q2 2022 Aug 11, 2022	BUY	$7.88 - $14.82 $23,726 - $44,623	3,011 Added 16.77%	20,963 $266,000
Q1 2022 May 13, 2022	SELL	$12.94 - $29.65 $26,112 - $59,833	-2,018 Reduced 10.11%	17,952 $252,000
Q4 2021 Feb 11, 2022	BUY	$26.43 - $34.5 $17,893 - $23,356	677 Added 3.51%	19,970 $578,000
Q3 2021 Nov 04, 2021	SELL	$22.71 - $36.69 $13,217 - $21,353	-582 Reduced 2.93%	19,293 $578,000
Q2 2021 Aug 11, 2021	BUY	$24.21 - $35.89 $99,987 - $148,225	4,130 Added 26.23%	19,875 $527,000
Q1 2021 May 13, 2021	BUY	$26.98 - $50.17 $73,088 - $135,910	2,709 Added 20.78%	15,745 $489,000
Q4 2020 Feb 16, 2021	BUY	$22.85 - $48.44 $162,349 - $344,166	7,105 Added 119.79%	13,036 $429,000
Q3 2020 Nov 12, 2020	BUY	$16.05 - $34.91 $95,192 - $207,051	5,931 New	5,931 $207,000

Others Institutions Holding NRIX

# of Institutions

181

Shares Held

68.1M

Call Options Held

78K

Put Options Held

53.8K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $935M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account